Medicare for All's Price Tag
07 November 2019
Sally Pipes, Pacific Research Institute's President, CEO and Thomas W. Smith Fellow in Health Care Policy, discusses presidential hopeful Elizabeth Warren's "Medicare for All" plan and the candidate's inability to adequately explain how she would pay for it.
0:00 0:00

Related Podcasts

Price Controls, Single-Payer Systems and Other Disastrous Healthcare Ideas
04 April 2025
Sally Pipes, President and CEO of Pacific Research Institute, discusses her recently released book, “The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy and How to Keep It,” the horrible impacts of price controls, how single-payer healthcare systems fail children and cancer patients, and more.
The Negative Consequences of Drug Price Controls for Patients
02 September 2024
Sally Pipes, Founder and President of Pacific Research Institute, discusses the impact of drug price controls under the Inflation Reduction Act (IRA), what it means for research and development of life-saving medicines, and how the IRA's drug pricing provisions will reduce access to new cures and treatments and result in longer wait times for existing medicines.
Government Price Controls for Prescription Drugs Are Bad Medicine for Americans
28 June 2024
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.
Biden Price Controls Undermine Cancer Moonshot
01 March 2024
Sally Pipes, President and CEO at the Pacific Research Institute, discusses how President Biden's drug price controls undermine his Cancer Moonshot initiative, and the ultimate impact price controls will have on patient lives, innovation, and research and development.
Patients' Lives at Risk with Medicare's Dual Payment Scheme
09 November 2023
Dr. Keith Smith, Healthcare Expert and Cofounder and Managing Partner of the Surgery Center of Oklahoma, discusses how Medicare's dual payment scheme jeopardizes patient health, how site-neutral reimbursement provides transparency and allows the free market to step in, and other insights and lessons learned when bureaucratic bloat is taken out of the equation.
Medicare for All's False Promises
12 April 2019
Sally Pipes, President and CEO of the Pacific Research Institute, discusses recent clashes on health care policy, lessons learned from other countries regarding socialized medicine, and whether the Veterans Administration is a good example of how Medicare for all would fail.